345
Views
36
CrossRef citations to date
0
Altmetric
ARTICLES

Suppression of Experimental Autoimmune Uveoretinitis by Anti-IL-17 Antibody

, , , &
Pages 297-303 | Received 01 Sep 2008, Accepted 11 Jan 2008, Published online: 02 Jul 2009

REFERENCES

  • Sasamoto Y, Kawano Y I, Bouligny R, Wiggert B, Chader G J, Gery I. Immunomodulation of experimental autoimmune uveoretinitis by intravenous injection of uveitogenic peptides. Invest Ophthalmol Vis Sci 1992; 33: 2641–2649
  • Sasamoto Y, Kotake S, Yoshikawa K, Wiggert B, Gery I, Matsuda H. Interphotoreceptor retinoid-binding protein derived peptide can induce experimental autoimmune uveoretinitis in various rat strains. Curr Eye Res 1994; 13: 845–849
  • Mosmann T R, Coffman R L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145–173
  • Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Curr Eye Res 2001; 22: 312–318
  • Jones L S, Rizzo L V, Agarwal R K, Tarrant T K, Chan C C, Wiggert B, Caspi R R. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol 1997; 158: 5997–6005
  • Langrish C L, Chen Y, Blumenschein W M, Mattson J, Basham B, Sedgwick J D, McClanahan T, Kastelein R A, Cua D J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233–240
  • Bettelli E, Carrier Y, Gao W, Korn T, Strom T B, Oukka M, Weiner H L, Kuchroo V K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235–238
  • Bettelli E, Oukka M, Kuchroo V K. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345–350
  • Peng Y, Han G, Shao H, Wang Y, Kaplan H J, Sun D. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2007; 48: 4153–4161
  • Furuzawa-Carballeda J, Vargas-Rojas M I, Cabral A R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6: 169–175
  • Abe T, Satoh N, Nakajima A, Koizumi T, Tamada M, Sakuragi S. Characterization of a potent uveitopathogenic site derived from rat phosducin. Exp Eye Res 1997; 65: 703–710
  • Chung D R, Chitnis T, Panzo R J, Kasper D L, Sayegh M H, Tzianabos A O. CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med 2002; 195: 1471–1478
  • Inoki T, Yamagami S, Sakai R, Isobe M, Tsuru T, Kawashima H. Suppression of experimental autoimmune uveoretinitis by anti-alphabeta TCR monoclonal antibody. Jpn J Ophthalmol 2002; 46: 518–524
  • Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008; 49: 3058–3064
  • Moseley T A, Haudenschild D R, Rose L, Reddi A H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155–174
  • Harrington L E, Hatton R D, Mangan P R, Turner H, Murphy T L, Murphy K M, Weaver C T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123–1132
  • Lubberts E. IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?. Cytokine 2008; 41: 84–91
  • Yoshimura T, Sonoda K H, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, Yoshida H. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 2008; 20: 209–214
  • Amadi-Obi A, Yu C R, Liu X, Mahdi R M, Clarke G L, Nussenblatt R B, Gery I, Lee Y S, Egwuagu C E. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007; 13: 711–718
  • Takeuchi M, Yokoi H, Tsukahara R, Sakai J, Usui M. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis. Jpn J Ophthalmol 2001; 45: 463–469
  • Cruz A, Khader S A, Torrado E, Fraga A, Pearl J E, Pedrosa J, Cooper A M, Castro A G. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006; 177: 1416–1420
  • Park H, Li Z, Yang X O, Chang S H, Nurieva R, Wang Y H, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133–1141
  • Weaver C T, Harrington L E, Mangan P R, Gavrieli M, Murphy K M. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677–688
  • Luger D, Silver P B, Tang J, Cua D, Chen Z, Iwakura Y, Bowman E P, Sgambellone N M, Chan C C, Caspi R R. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008; 205: 799–810
  • Harrington L E, Mangan P R, Weaver C T. Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr Opin Immunol 2006; 18: 349–356
  • Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13: 139–145
  • Xu H, Rizzo L V, Silver P B, Caspi R R. Uveitogenicity is associated with a Th1-like lymphokine profile: Cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 1997; 178: 69–78

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.